Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Nebraska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Nebraska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Nebraska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Dean Arkfeld (NPI 1891797155)

Field	Value
Entity Type	Individual
Organization	Dean Arkfeld
Address	16820 Frances St
City	Omaha
State	NE
ZIP	68130
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 1, 2005

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the only payer activity on file: total Medicare revenue is $1.4M and there is no Medicaid billing on file, so DEAN ARKFELD is effectively a Medicare-only biller in the available data. The absence of Medicaid activity implies limited payer diversification and means analyses of payer mix should treat this profile as single-payer (Medicare) for reimbursement and volume exposure.

Revenue is highly concentrated in three intravitreal injection drugs: the precomputed top-3 Medicare codes account for 75.5% of this provider’s total Medicare revenue, led by J2777 at $725.6K (51.4%), followed by J2778 at $170.5K (12.1%) and J0178 at $170.2K (12.0%). This concentration indicates that a small set of drug-administering procedures dominate the practice’s Medicare income, which has operational and purchasing implications for drug inventory, payer contracting, and reimbursement risk.

The procedure mix (dominant J2777, J2778, J0178 injections plus high volumes of retinal imaging and follow-up exam codes) points to a retina-focused ophthalmology practice that routinely provides intravitreal medication management. Codes such as 92134 (retinal imaging), 92014 (comprehensive established exam), and 67028 (isolated intravitreal injection procedure) together support a clinical model centered on medical retina care and frequent follow-up visits.

Although J2777 (faricimab) is the single largest revenue driver at $725.6K (51.4% of Medicare revenue), the provider’s national standing for that code is mid-range: the code ranks #386 of 2039 providers nationally (81th percentile) and is labeled “typical, unremarkable volume.” In practice this means the provider depends heavily on faricimab revenue internally but does not appear to be an unusually high-volume outlier for J2777 when compared to national peers.

Service-level volume for office-based ophthalmology care is an outlier: 92014 shows 1.4K claims and $109.1K revenue (7.7% of Medicare revenue) and ranks #691 of 35415 providers nationally (98th percentile), described as an “extreme outlier.” That very high volume of established-patient comprehensive exams suggests a large, active patient panel or a practice workflow that generates many follow-up/comprehensive visits alongside intravitreal therapy.

Retinal diagnostic imaging is also a notable strength: 92134 has 1.6K claims and $42.3K revenue (3.0% of Medicare revenue) and ranks #1445 of 26868 providers nationally (95th percentile), characterized as “notably above typical national volume.” High imaging volumes corroborate the retina-focused service line and indicate substantial use of OCT or similar posterior-segment imaging as part of routine management.

Competitive standing across the major injectable agents is mixed: J2778 (ranibizumab) is $170.5K (12.1%) and ranks #455 of 1208 (62th percentile) while J0178 (aflibercept) is $170.2K (12.0%) and ranks #2451 of 3204 (23th percentile), both labeled “typical, unremarkable volume.” These ranks indicate the provider is a solid regional participant for some agents but not a dominant national player across all injectable drugs, with relative strength concentrated in faricimab.

Provider tenure is long-standing: the NPI was enumerated on 2005-06-01 (~21 years ago), which supports interpreting current volume and coding patterns as those of an established ophthalmology clinician rather than a recent entrant; longevity can influence referral relationships and patient panel stability relevant to payers and contracting teams.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

18 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	25,020	$30	$725.6K
J2778	Injection, ranibizumab, 0.1 mg	940	$180	$170.5K
J0178	Injection, aflibercept, 1 mg	250	$690	$170.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	1,440	$80	$109.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	770	$80	$61.3K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,570	$30	$42.3K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	350	$120	$41.4K
66821	The provider removes the haziness from the capsule of the eye using a laser for a patient with a secondary membranous cataract.	120	$230	$26.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	290	$60	$16K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	150	$90	$13.1K

Showing 1–10 of 18

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 18 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Nebraska Distribution

Dean Arkfeld — 2 of 18 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Nebraska

Full comparison — all codes billed, vs. state median

18 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	8	10	25,950	$30	$1.5M
J0178	13	20	880	$690	$722.7K
J2778	4	10	670	$180	$137.8K
67028	13	20	1,070	$80	$106.4K
J2781	2	10	340	$120	$47.8K
66821	28	80	80	$210	$23K
92014	2	270	170	$70	$20K
99214	1,235	3,210	110	$70	$14.9K
92235	10	10	30	$100	$11.2K
99213	434	3,220	90	$50	$7.9K

Showing 1–10 of 18

Related Providers

Other providers that share a Tax Identification Number (TIN) with Dean Arkfeld, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Brandon Menke	NE	Ophthalmology Physician	$372.2K	$0
Peter Simone	NE	Ophthalmology Physician	$196.8K	$0
Michael Goldstein	NE	Ophthalmology Physician	$176.4K	$0

Nearby Providers

Other providers in the same ZIP code as Dean Arkfeld, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Alegent Creighton Health	NE	General Acute Care Hospital	$0	$4.3M
Luke Nordquist	NE	Hematology & Oncology Physician	$3.7M	$0
Samuel Mehr	NE	Nuclear Medicine Physician	$2.5M	$0
Omegavision PC	NE	Optometrist	$0	$1.4M
New Century Physicians Of Nebraska LLC	NE	Emergency Medicine Physician	$0	$917.9K
Heartland Family First Medical Clinic, LLC	NE	Pediatrics Physician	$0	$899.3K
Lakeside Ambulatory Surgical Center LLC	NE	Ambulatory Surgical Clinic/Center	$557.1K	$0
Omaha Anesthesia Associates LLC	NE	Anesthesiology Physician	$0	$517.9K
Children's Rehab - Occupational Therapy	NE	Pediatric Occupational Therapist	$0	$388.1K
Beyond Care Pediatrics LLC	NE	Pediatrics Physician	$0	$354.5K

Dean Arkfeld — Billing Profile & Reimbursement Data

Sign up for Dean Arkfeld — Billing Profile & Reimbursement Data policy alerts

Dean Arkfeld — Billing Profile & Reimbursement Data

Sign up for Dean Arkfeld — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References